| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Cowen Aaron | 10%+ Owner | C/O SUVRETTA CAPITAL MANAGEMENT, LLC, 540 MADISON AVENUE, 7TH FLOOR, NEW YORK | /s/ Aaron Cowen | 11 Jul 2025 | 0001869640 |
Aaron Cowen is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
The beneficial ownership information of Aaron Cowen (the "Reporting Person") has not changed from information set forth in the Form 3 filed by the Reporting Person on October 22, 2024. This "exit" Form 4 is voluntarily filed solely to report that the Reporting Person is no longer the beneficial owner of more than 10% of the outstanding shares Class A common stock, par value $0.0001 per share (the "Class A common stock"), of ProKidney Corp. (the "Issuer"), based on the number of shares of the Class A common stock outstanding as reported by the Issuer on July 3, 2025 in the Post-Effective Amendment No. 1 to the Registration Statement on Form S-3 filed on July 3, 2025 with the Securities and Exchange Commission.